These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18786481)

  • 21. [Suspected heart failure: how important is the BNP-testing for the general practitioner?].
    Pfister R; Erdmann E
    MMW Fortschr Med; 2009 Apr; 151(15):31-2. PubMed ID: 19728678
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Souverijn JH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):231; author reply 231. PubMed ID: 18320951
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to "Getting the right message".
    Januzzi JL; Camargo CA; Tung R
    Ann Emerg Med; 2007 Mar; 49(3):381-3; discussion 383; author reply 384. PubMed ID: 17317512
    [No Abstract]   [Full Text] [Related]  

  • 24. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of B-type natriuretic peptide in paediatric patients: a review of literature.
    Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On "Getting the right message".
    Collins SP
    Ann Emerg Med; 2007 Mar; 49(3):383-4; author reply 384. PubMed ID: 17317514
    [No Abstract]   [Full Text] [Related]  

  • 29. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Cons].
    Andreuzzi B; Mangiavacchi M; Pini D; Municinò A; Genovese L; Tomaello L; Gronda E
    Ital Heart J; 2003 Dec; 4 Suppl 8():68S-72S. PubMed ID: 15005535
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management.
    Singer AJ; Birkhahn RH; Guss D; Chandra A; Miller CD; Tiffany B; Levy P; Dunne R; Bastani A; Thode HC; Hollander JE
    Circ Heart Fail; 2009 Jul; 2(4):287-93. PubMed ID: 19808351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptide testing in primary care.
    Murphy JJ; Fuat A
    Circulation; 2006 Mar; 113(9):f35-6. PubMed ID: 16523535
    [No Abstract]   [Full Text] [Related]  

  • 33. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
    Ibrahim A; Baibars M; Alraies MC; Oliveira GH
    Cleve Clin J Med; 2012 Jan; 79(1):22-5. PubMed ID: 22219230
    [No Abstract]   [Full Text] [Related]  

  • 34. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
    van Kimmenade RR; Pinto Y; Januzzi JL
    Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
    [No Abstract]   [Full Text] [Related]  

  • 35. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
    Cleland JG; Squire I; Ng L
    J Am Coll Cardiol; 2008 Sep; 52(13):1104-5. PubMed ID: 18848145
    [No Abstract]   [Full Text] [Related]  

  • 36. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
    Maisel A
    J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptides and the general practitioner.
    Mueller C
    J Am Coll Cardiol; 2007 Oct; 50(17):1702-3. PubMed ID: 17950154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.